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Letter to the Editor
Extreme Pathways and Kirchhoff’s Second Law
Constraints-based models
As an alternative to kinetic models for the analysis of
genome-scale networks, data-driven constraints-based mod-
els have emerged. Constraints-based modeling is centered
on the successive application of fundamental physicochem-
ical constraints and experimental data on the function of
reconstructed genome-scale networks to narrow the range of
their possible functions (Palsson, 2000). This approach has
proven successful for modeling cellular metabolism (Ed-
wards et al., 2001). Analytical tools such as flux balance
analysis (FBA), and extreme pathway analysis (ExPA) uti-
lize mass, redox, and energy balance constraints to model
steady-state behavior of reconstructed networks. FBA uses
linear optimization to find a flux distribution that maximizes
a stated objective function (Varma and Palsson 1994; Bona-
rius et al., 1997), and ExPA describes all the possible
steady-state flux distributions of the network (Schilling et
al., 2000). The application of mass balance constraints in
FBA and ExPA is analogous to Kirchhoff’s first law for
electrical circuits: namely the production and utilization rate
of a metabolite must balance in a steady state. Further
utilized constraints are based on the thermodynamic irre-
versibility of reactions and the maximum flux through any
reaction or transporter.
Systemic thermodynamic constraints
A recent paper (Beard et al., 2002) provides a framework
for incorporating systemic thermodynamic constraints anal-
ogous to Kirchhoff’s second law into constraints-based
models. Just as the voltage drop around a closed loop in an
electrical circuit must be zero, so too must the free energy
change around a biochemical loop be equal to zero, because
free energy is a state variable. When multispecies reactions
are included in the network, closed reaction loops can be
identified through an algebraic transformation of the stoi-
chiometric matrix (Beard et al., 2002). Going around a loop
returns the system to the same state from which it originated
(see Fig. 1). For example, any series of reaction steps that
together has an overall reaction of A  2B  C3 A  2B
 C must have a free energy change of zero. From the
second law of thermodynamics, each reaction in the net-
work must have a negative free energy change in the direc-
tion of the net flux. No net flux is possible through a
balanced biochemical loop in the steady state. Thus the
application of the loop constraint will not change the opti-
mal value of an objective function, such as production of
biomass, that is composed of throughput fluxes. However, it
does restrict the allowable intracellular distribution of
fluxes.
Extreme pathways and the loop law
The method of Beard et al. (2002) involves a bilinear
constraint on fluxes and free energies, resulting from im-
plementation of the second law of thermodynamics. How-
ever, if only fluxes are to be computed, the loop constraint
can be applied using the extreme pathways without the need
for a bilinear optimization. Extreme pathways are a set of
convex basis vectors that describe all the steady-state func-
tions of a biochemical network (Schilling et al., 2000).
Extreme pathways are flux maps through a biochemical
network that have the following properties: 1) they are a
unique set of convex basis vectors that circumscribe all
possible steady-state flux distributions through the network;
2) they characterize time invariant properties of biochemical
networks; 3) they are contiguous sets of fluxes (a flux map)
that each satisfy the mass balance of the system and reaction
irreversibility constraints; and 4) they can have multiple
inputs or outputs (Price et al., 2002). Extreme pathways can
be divided into three basic categories based upon their
exchange fluxes (Schilling et al., 2000). Each of these three
categories can be understood relative to energy usage.
Type I extreme pathways are those that have exchange
fluxes across the system boundaries that correspond to
noncurrency metabolites (Fig. 2, left). These extreme path-
ways can be energetically interpreted analogously to charg-
ing a battery. These extreme pathways drive the cycling of
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metabolic currencies, such as ATP, which then drive other
cellular processes.
Type II extreme pathways are those that have “exchange
fluxes” corresponding only to currency metabolites (e.g.,
ATP, NADH), with the rest of the pathway being an internal
cycle (Fig. 2, center). These pathways represent futile cy-
cles and are analogous to draining a battery. They are
unidirectional in the absence of a driving force on the
cofactor pool.
Type III extreme pathways are those that have no ex-
change fluxes (Fig. 2, right). Thus, these represent internal
cycles. The fluxes through interior cycles must necessarily
be zero to satisfy the loop constraints.
FIGURE 3 Simple illustration of loop constraint.
FIGURE 4 Extreme pathways of an example system. There are three
type I extreme pathways, and six type III extreme pathways. Three of the
type III extreme pathways correspond simply to the reversible reactions.
Solutions that are non-negative linear combinations of only the type I
extreme pathways account for all possible flux distributions in the network
that do not violate the loop law.
FIGURE 2 Types of Extreme Pathways. Type I extreme pathways are those that have exchange fluxes across the system boundaries that correspond to
noncurrency metabolites. Type II extreme pathways have only currency metabolites that cross system boundaries. These currency metabolites can thus be
thought of as being accumulated or depleted in the cell. Type III extreme pathways do not contain any exchange fluxes, and thus correspond to internal
loops.
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The imposition of the loop law on the reaction fluxes is
equivalent to setting the flux through type III extreme
pathways to zero. Type III extreme pathways can be calcu-
lated for any defined biochemical network by not allowing
any fluxes to cross system boundaries. This generated set of
type III extreme pathways then forms a convex basis for all
the complex internal loops existing in the network. The use
of a type III pathway can be readily eliminated in the FBA
solution, thus removing thermodynamically disallowed cy-
cles. This constraint is equivalent to that proposed in Beard
et al. (2002), and can be applied without needing to do a
bilinear optimization.
Simple examples
A simple example system can demonstrate how the loop
constraints work (Fig. 3). This simple example is chosen for
conceptual clarity and does not represent biochemically
realistic systems. However, the principles outlined in the
example are the same as for realistic biochemical loops.
Figure 3 A shows an example FBA solution that balances
the fluxes through the system and does not violate the
directionality of any of the reactions. All FBA solutions can
be decomposed into weightings on the extreme pathways.
For the example system, two extreme pathways describe the
system. The weightings of the two extreme pathways are
shown in Fig. 3 B. However, the loop law disallows the
internal cycle represented by extreme pathway 2 (EP2). The
disallowed cycle can be readily eliminated from the solution
as a post-processing step, leaving a solution that does not
violate the loop law (Fig. 3 C).
A slightly more complicated example system is shown in
Fig. 4, with all of the reversible reactions decoupled into
two separate reactions. This example system contains nine
FIGURE 5 Application of the loop
law to FBA solutions. (A) A flux
distribution that satisfies mass bal-
ance. However, this solution violates
the loop law. Type III extreme path-
ways can be used to eliminate infea-
sible loops. (B) The first type III ex-
treme pathway has a value of one.
(C) The resulting flux distribution
with the loop shown in (B) elimi-
nated. (D) A second type III extreme
pathway is left in the solution. (E)
The final solution with the extreme
pathway shown in (D), with a
weighting of two, eliminated from
the solution. The dotted lines indi-
cate that a reaction is reversible.
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extreme pathways: three type I extreme pathways and six
type III extreme pathways. These extreme pathways form a
set of biochemically realistic basis vectors for the flux
solution space. All possible steady-state flux distributions
must be non-negative linear combinations of the extreme
pathways. Application of the loop constraint requires that
the flux through all of the type III extreme pathways be set
to zero. Thus, the type III extreme pathways are effectively
eliminated from the convex basis, leaving only the three
type I extreme pathways to span the flux solution space.
Non-negative combinations of these three extreme path-
ways yield all of the steady-state flux distributions that do
not violate the loop law.
An example FBA solution for the example network in
Fig. 4 is shown in Fig. 5 A. It is not necessary to completely
decouple a solution into weightings on extreme pathways to
apply the loop law. Once the type III extreme pathways
have been calculated, the network simply needs to be
searched for these cycles, and each cycle that exists in the
solution needs to be eliminated until no more are present.
The minimum weighting on the type III extreme pathway
needed to eliminate the loop is used. In the simple example
system of Fig. 5, the FBA solution contains two loops that
need to be deleted. As shown in Fig. 5 B, the bottom type III
needs to be deleted. The minimum flux value in the loop
relative to the stoichiometry of the extreme pathways is
used to determine the magnitude of the type III extreme
pathway being used, which, in this case, is 1. Once this flux
is deleted (Fig. 5 C), only one loop remains. This loop is the
combination of the two type III extreme pathways deter-
mined earlier (Fig. 5 D). The minimum flux value is 2, and
so the loop is scaled accordingly and deleted from the
solution. With the loops removed, a valid solution remains
that does not violate the loop law.
A priori knowledge of irreversibility
Appropriately defining irreversible reactions can capture to
a significant degree the constraints imposed by the loop law.
Upon examination of the sample system, it can be seen that
the three reactions that are shown to be reversible are
actually constrained to be unidirectional based solely on the
loop law. In the example system of Fig. 4, setting the three
initially reversible reactions to be irreversible (left to right)
would constrain the solution space exactly as it was con-
strained by the application of the loop law: only the type I
extreme pathways would have been calculated. Thus, in
many cases, the inclusion of irreversibility constraints on
many reactions, as has commonly been done in FBA, can
encapsulate a good portion of the thermodynamic informa-
tion. Equivalently, application of the loop law can recover
irreversibility constraints that have not been implemented a
priori.
Recapitulation
The application of the loop law to eliminate thermodynam-
ically infeasible solutions gives us an additional set of
useful physicochemical constraints to determine allowable
behavior of biochemical reaction networks. By utilizing the
type III extreme pathways, the loop law can be implemented
in flux balance without needing to perform a bilinear opti-
mization. The importance of adding these constraints into
genome-scale models now needs to be evaluated. In addi-
tion, the energy balance theory presented by Beard et al.
(2002) provides a foundation for constraints-based analysis
of reaction-free energies in large-scale biochemical systems
and thus expands the scope of information available from
constraints-based modeling of biochemical networks.
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